Medfinder
Expert medication guides

The Found Script

Go beyond finding medications. Expert guides, shortage updates, and tips for navigating the healthcare system.

2760 articles in Drug ShortagesClear all filters
Ciprodex Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Ciprodex Shortage: What Providers and Prescribers Need to Know in 2026

A clinical briefing on Ciprodex availability in 2026. Learn about supply status, prescribing implications, alternatives, and tools to help your patients.

By Peter Daggett·
Why is Crexont XR so hard to find? [Explained for 2026]
Drug Shortages

Why is Crexont XR so hard to find? [Explained for 2026]

Wondering why Crexont is so hard to find at your pharmacy? Learn the reasons behind limited availability and what you can do about it in 2026.

By Peter Daggett·
Crexont XR shortage update: What patients need to know in 2026
Drug Shortages

Crexont XR shortage update: What patients need to know in 2026

Is Crexont in shortage in 2026? Get the latest update on Crexont availability, what's causing supply issues, and what patients can do right now.

By Peter Daggett·
Paxlovid 150 Mg /100 Mg Dose Pack Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Paxlovid 150 Mg /100 Mg Dose Pack Shortage: What Providers and Prescribers Need to Know in 2026

A provider-focused update on Paxlovid 150 Mg /100 Mg Dose Pack availability in 2026, including prescribing considerations, drug interactions, and patient access tools.

By Peter Daggett·

30,000+ have already found their meds with Medfinder.

Stop calling pharmacies. Start your search today.

Symproic Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Symproic Shortage: What Providers and Prescribers Need to Know in 2026

A provider-focused update on Symproic (Naldemedine) availability in 2026. Covers supply status, prescribing considerations, cost, and patient access tools.

By Peter Daggett·
Why Is Buprenorphine/Naloxone So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Buprenorphine/Naloxone So Hard to Find? [Explained for 2026]

Struggling to find Buprenorphine/Naloxone in stock? Learn why this medication is hard to find in 2026, what's causing supply issues, and what you can do.

By Peter Daggett·
For Healthcare ProvidersDrug Shortages

Ketorolac Shortage: What Providers and Prescribers Need to Know in 2026

A clinical briefing on the Ketorolac (Toradol) shortage for providers. Timeline, prescribing implications, alternatives, and tools to help patients.

By Peter Daggett·
Why Is Diazepam So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Diazepam So Hard to Find? [Explained for 2026]

Wondering why Diazepam is so hard to find in 2026? Learn the real reasons behind Diazepam shortages and what you can do to fill your prescription today.

By Peter Daggett·
Why Is Iyuzeh So Hard to Find? [Explained for 2026]
Drug Shortages

Why Is Iyuzeh So Hard to Find? [Explained for 2026]

Struggling to find Iyuzeh at your pharmacy? Learn why this preservative-free glaucoma eye drop is hard to find in 2026 and what you can do about it.

By Peter Daggett·
Drug Shortages

Roszet Shortage Update: What Patients Need to Know in 2026

Roszet has been permanently discontinued in 2026. Here's what patients need to know about availability, cost, alternatives, and next steps.

By Peter Daggett·
Ganirelix Shortage: What Providers and Prescribers Need to Know in 2026
For Healthcare ProvidersDrug Shortages

Ganirelix Shortage: What Providers and Prescribers Need to Know in 2026

A provider briefing on Ganirelix availability in 2026. Supply chain analysis, prescribing alternatives, cost considerations, and tools to help patients.

By Peter Daggett·
For Healthcare ProvidersDrug Shortages

Cepastat Sore Throat & Cough Shortage: What Providers and Prescribers Need to Know in 2026

A provider-focused update on the Cepastat Sore Throat & Cough shortage in 2026. Availability, alternatives, and clinical guidance for prescribers.

By Peter Daggett·
PreviousPage 122 of 230Next